
News|Articles|June 1, 2004
New molecular entity: Apomorphine injection
First therapy approved for “off” episodes in advanced Parkinson’s disease
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Overlooked bladder nerves now thought to reduce UTI burden through pain signaling, study shows
2
Real-World Usage of Biologics in Psoriatic Arthritis
3
Medicare beneficiaries are paying more for price-negotiated drugs, survey finds
4
Researchers discover new pathway to fight liver inflammation
5





















